Breaking news

Saudi Arabia’s AI Surge: Leading The Charge In Women’s Empowerment And Job Growth

Saudi Arabia has cemented its position as a rising powerhouse in artificial intelligence, securing the top global ranking for women’s empowerment in AI, according to Stanford University’s AI Index Report 2025. The Kingdom is also making waves in AI job growth, talent attraction, and cutting-edge model development—key indicators of its broader push to dominate the global AI landscape.

AI Talent And Job Growth: A Strategic Push

Saudi Arabia’s aggressive investment in AI is paying off. The Kingdom now ranks third worldwide in AI job growth for 2024 and fourth in developing leading AI models. It stands alongside the United States, China, France, Canada, and South Korea as one of only seven nations producing advanced AI models—an impressive feat for a country rapidly scaling its digital economy.

A Rising AI Hub: Attracting Global Talent

Ranked eighth globally in AI talent attraction, Saudi Arabia is becoming a magnet for top-tier professionals. Strategic initiatives, a robust research ecosystem, and a business-friendly regulatory framework make the Kingdom an increasingly attractive destination for AI experts seeking opportunities in a fast-growing market.

Women At The Forefront Of AI

Perhaps the most striking achievement is Saudi Arabia’s global leadership in empowering women in AI, with the highest female-to-male ratio in the sector. This milestone is the result of targeted national policies that foster inclusion, skills development, and leadership opportunities for women in technology. Programs like “Elevate,” a partnership with Google Cloud designed to train over 25,000 women in AI and tech, are shaping a new generation of female AI leaders. Additional initiatives, including specialized training camps and capacity-building programs, are reinforcing the Kingdom’s commitment to gender diversity in STEM fields.

Saudi Arabia’s AI Vision: Scaling To Global Leadership

At the heart of Saudi Arabia’s AI dominance is the Saudi Data and Artificial Intelligence Authority (SDAIA), which is spearheading national efforts to drive AI adoption. SDAIA’s strategy focuses on enhancing digital infrastructure, developing policy frameworks, and accelerating AI investment to position Saudi Arabia as a global leader in artificial intelligence. These moves align seamlessly with the ambitious goals of Vision 2030, which aims to transform the Kingdom into a knowledge-driven economy powered by innovation.

As Saudi Arabia continues its AI expansion, the message is clear: the Kingdom is not just participating in the AI revolution—it’s setting the pace.

Medochemie And Theramir Announce Strategic Investment Agreement To Advance Biotech Manufacturing In Cyprus

Pharmaceutical manufacturer Medochemie and biotechnology company Theramir, both Cyprus-based, have announced a strategic investment agreement and collaboration aimed at developing next-generation biological therapies and expanding manufacturing capabilities in Cyprus.

The agreement, announced on 2 September 2026, brings together Medochemie’s experience in pharmaceutical manufacturing and Theramir’s biotechnology research. The companies said the collaboration would support advanced pharmaceutical manufacturing in Cyprus and south-eastern Europe.

What The Partnership Covers

Medochemie’s contribution will include its expertise in manufacturing sterile therapeutic products and its access to international markets.

Theramir develops technologies based on extracellular vesicles and microRNAs. Its work includes using stem-cell-derived extracellular vesicles to deliver microRNAs, small, non-coding RNA molecules that regulate genes and biological pathways associated with cancer growth and metastasis.

Under the agreement, the companies will jointly support the development of “Good Manufacturing Practice” capabilities for next-generation biological therapies. The partnership is also intended to help move these therapies towards clinical development.

A Wider Role For Cyprus

The collaboration will also support Theramir’s wider research programme. According to the companies, it is intended to strengthen Cyprus’s biotechnology infrastructure and expand local capacity in next-generation biomanufacturing.

They present the agreement as a step towards giving Cyprus a larger role in biotechnology and advanced pharmaceutical manufacturing for south-eastern Europe and international markets.

The Future Forbes Realty Global Properties
eCredo
Aretilaw firm
Uol

Become a Speaker

Become a Speaker

Become a Partner

Subscribe for our weekly newsletter